Amatuximab

Amatuximab ^?

Monoclonal antibody
Type	Whole antibody
Source	Chimeric (mouse/human)
Target	mesothelin
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
CAS number	931402-35-6 N
ATC code	None
Chemical data
Formula	C6394H9870N1694O2024S46
Mol. mass	144.33 kDa (peptide)
N(what is this?)  (verify)

Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.^[1]

Amatuximab was developed by Morphotek, Inc.

References

1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Amatuximab". American Medical Association. http://www.ama-assn.org/resources/doc/usan/amatuximab.pdf. 

v · d · eMonoclonal antibodies for tumors Tumor ("-t(u[m])-") Human ("-tumu-") Adecatumumab • Belimumab • Cixutumumab • Conatumumab • Daratumumab • Drozitumab • Figitumumab • Ganitumab • Glembatumumab vedotin • Intetumumab • Iratumumab • Lexatumumab • Lucatumumab • Mapatumumab • Narnatumab • Necitumumab • Ofatumumab • Olaratumab • Panitumumab • Pritumumab • Radretumab • Rilotumumab • Robatumumab • Teprotumumab • Votumumab • Zalutumumab "-melu-" (melanoma): Flanvotumab Mouse ("-tumo-") Altumomab pentetate • Anatumomab mafenatox • Arcitumomab • Bectumomab • Blinatumomab • CC49 • Detumomab • Ibritumomab tiuxetan • Minretumomab • Mitumomab • Moxetumomab pasudotox • Naptumomab estafenatox • Nofetumomab merpentan • Pemtumomab† • Pintumomab • Racotumomab • Satumomab pendetide • Taplitumomab paptox • Tenatumomab • Tositumomab • 3F8 "-govo-" (ovarian tumor): Abagovomab • Igovomab • Oregovomab "-pro-" (prostate tumor): Capromab pendetide "-colo-" (colonic tumor): Edrecolomab • Nacolomab tafenatox Chimeric ("-tuxi-") Amatuximab • Bavituximab • Brentuximab vedotin • Cetuximab • Ensituximab • Girentuximab • Indatuximab ravtansine • Rituximab • Siltuximab • Ublituximab "-mexi-" (melanoma): Ecromeximab Humanized ("-tuzu-") Afutuzumab • Alemtuzumab • Bevacizumab • Bivatuzumab mertansine • Cantuzumab mertansine • Cantuzumab ravtansine • Citatuzumab bogatox • Clivatuzumab tetraxetan • Dacetuzumab • Dalotuzumab • Elotuzumab† • Etaracizumab • Farletuzumab • Ficlatuzumab • Gemtuzumab ozogamicin • Inotuzumab ozogamicin • Labetuzumab • Lintuzumab • Lorvotuzumab mertansine • Matuzumab§ • Milatuzumab • Nimotuzumab • Onartuzumab • Oportuzumab monatox • Pertuzumab • Sibrotuzumab • Tacatuzumab tetraxetan • Tigatuzumab • Trastuzumab • Tucotuzumab celmoleukin • Veltuzumab Rat/mouse hybrid ("-tumaxo-") Catumaxomab • Ertumaxomab #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III

This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.v · d · e

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.v · d · e

This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)